Back to catalogue
TET
Treatt PLC
400/1000 Overall fit
AI beneficiary 35% 20
Operating leverage 25% 65
Valuation 25% 30
Downside protection 15% 60
First-pass take
Treatt is a cyclical ingredient supplier showing severe revenue and profit contraction (-11.8% and -44.4% respectively), reflecting macro headwinds and margin compression. While operational leverage structure is sound, it currently pressures returns. AI is mentioned only as exploratory internal tools for R&D and operations, not material to revenue or strategy. Balance sheet remains solid (30.1x interest cover) but net debt worsened post-buyback.
Flags
cyclicalm-and-a-riskno-valuation-datagovernance-riskrevenue-declinemargin-pressure